Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profiles

Authors:

Abstract
Infections caused by carbapenem-resistantEnterobacteriaceae(CRE) are alarming in the clinical setting, as CRE isolates often exhibit resistance to most clinically-available antibiotics.Klebsiella pneumoniaecarbapenemase (KPC) is the most common carbapenemase carried by CRE in North America and Europe, frequently detected in isolates ofK.pneumoniae,Escherichia coli, andEnterobacter cloacae. Notably, KPC-expressing strains often arise from clonal lineages, with sequence type 258 (ST258) representing the dominant lineage inK.pneumoniae, ST131 inE.coli, and ST78 and ST171 inE.cloacae. Prior studies have demonstrated that carbapenem-resistantK.pneumoniaediffers from carbapenem-susceptibleK.pneumoniaeat both the transcriptomic and soluble metabolomic levels. In the present study, we sought to determine whether carbapenem-resistant and carbapenem-susceptible isolates ofK.pneumoniae,E.coli, andE.cloacaeproduce distinct volatile metabolic profiles. We were able to identify a volatile metabolic fingerprint that could discriminate between CRE and non-CRE with an area under the receiver operating characteristic curve (AUROC) as high as 0.912. Species-specific AUROCs were as high as 0.988 forK.pneumoniaeand 1.000 forE.cloacae. Paradoxically, curing of KPC-expressing plasmids from a subset ofK.pneumoniaeisolates further accentuated the metabolic differences observed between ST258 and non-ST258.

This publication has 62 references indexed in Scilit: